Adagene (ADAG) Accumulated Expenses (2019 - 2025)

Adagene's (ADAG) quarterly Accumulated Expenses came in at $2790.8 billion in Q4 2025, down 0.9% year-on-year from $2816.0 billion in Q4 2024, and up 75913576.7% on a QoQ basis from $3.7 million in Q2 2025.

Adagene (ADAG) Accumulated Expenses (2019 - 2025) Analysis & Trends

Adagene (ADAG) has 7 years of Accumulated Expenses data on file, last reported at $2790.8 billion in Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 0.9% year-over-year to $2790.8 billion in Q4 2025; TTM through Dec 2025 was $2790.8 billion, a 0.9% decrease from a year earlier, with the FY2025 full-year figure at $2790.8 billion, down 0.9% from the prior year.
  • Accumulated Expenses for Q4 2025 stood at $2790.8 billion, up from $3.7 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for ADAG reached as high as $4237.6 billion in Q2 2022 and fell as low as $2.7 million in Q2 2024.
  • Historically, Accumulated Expenses has averaged $1889.3 billion across 5 years, with a median of $2803.4 billion in 2024.
  • Across the five-year window, Accumulated Expenses surged 119089996.15% in 2022 and tumbled 100.0% in 2024, its largest moves.
  • Year by year, Accumulated Expenses stood at $4.4 million in 2021, then surged by 73364383.31% to $3212.8 billion in 2022, then decreased by 6.58% to $3001.5 billion in 2023, then slipped by 6.18% to $2816.0 billion in 2024, then decreased by 0.9% to $2790.8 billion in 2025.
  • Per Business Quant data, the three most recent Accumulated Expenses figures were $2790.8 billion in Q4 2025, $3.7 million in Q2 2025, and $2816.0 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Adagene 198.85 Mn 198.85 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2,790.79 Bn
Jun 30, 2025 3.68 Mn
Dec 31, 2024 2,816.04 Bn
Jun 30, 2024 2.66 Mn
Dec 31, 2023 3,001.51 Bn
Jun 30, 2023 2,834.57 Bn
Dec 31, 2022 3,212.81 Bn
Jun 30, 2022 4,237.62 Bn
Dec 31, 2021 4.38 Mn
Jun 30, 2021 3.56 Mn
Dec 31, 2020 6.06 Mn
Dec 31, 2019 2.54 Mn